We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Cites ANIP for Lack of Specifications
Warning Letter Cites ANIP for Lack of Specifications
September 11, 2009
The FDA has warned ANIP Acquisition Company for a lack of dissolution, solubility and viscosity specifications for drugs and asked the company to stop marketing 30 unapproved products.